Muir-Torre Syndrome
case report and molecular characterization
Keywords:
Muir-Torre syndrome, Colorectal neoplasms, hereditary nonpolyposis, Pathology, molecular, Microsatellite instability, MutationAbstract
CONTEXT: Muir-Torre syndrome is a rare autosomal dominant genodermatosis caused by mutations in the mismatch repair genes. It is characterized by the presence of sebaceous skin tumors and internal malignancies, affecting mainly the colon, rectum and urogenital tract. Awareness of this syndrome among physicians can lead to early diagnosis of these malignancies and a better prognosis. CASE REPORT: We report the case of a Chilean patient who, over the course of several years, had multiple skin lesions, endometrial cancer and colon cancer. The syndrome was diagnosed using molecular techniques such as microsatellite instability analysis, immunohistochemistry and DNA sequencing, which allowed us to find the causative mutation. CONCLUSION: Molecular diagnostics is a highly useful tool, since it allows clinicians to confirm the presence of mutations causing Muir-Torre syndrome. It is complementary to the analysis of the clinical data, such as dermatological presentation, presence of visceral malignancies and family history of colorectal tumors, and it provides important knowledge to help physicians and patients choose between treatment options.
Downloads
References
Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33(1):90-104.
Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005;6(12):980-7.
Kruse R, Rütten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63(1):63-70.
Lynch HT, Lynch PM, Lanspa SJ, et al. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76(1):1-18.
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348(10):919-32.
Silva FC, Valentin MD, Ferreira Fde O, Carraro DM, Rossi BM. Mismatch repair genes in Lynch syndrome: a review. Sao Paulo Med J. 2009;127(1):46-51.
Ponti G, Losi L, Di Gregorio C, et al. Identification of Muir- Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer. 2005;103(5):1018-25.
Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248-57.
Ko CJ. Muir-Torre syndrome: Facts and controversies. Clin Dermatol. 2010;28(3):324-9.
Tavakkol Z, Keller JJ, Furmanczyk PS, Bennett RL, Chien AJ. Germline mutation in MSH6 associated with multiple malignant neoplasms in a patient with Muir-Torre syndrome. J Clin Oncol. 2012;30(22):e195-8.
Levati L, Marra G, Lettieri T, et al. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer. 1998;23(2):159-66.
Ponti G, Pellacani G, Seidenari S, et al. Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes. Crit Rev Oncol Hematol. 2013;85(3):239-56.
Ponti G, Ponz de Leon M, Maffei S, et al. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet. 2005;68(5):442-7.
Santos BMR, Conceição SA, Fontes D, et al. Síndrome de Muir-Torre: relato de caso [Muir-Torre`s syndrome: case story]. Rev Bras Colo- proctol. 2002;22(4):260-3.
Chabelmann RC, Nico MM. Multiple keratoses and yellow papules. Clin Exp Dermatol. 2008;33(6):797-8.
Lee BA, Yu L, Ma L, Lind AC, Lu D. Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co-existing visceral tumors. J Am Acad Dermatol. 2012;67(6):1228-34.
Mecklin JP, Järvinen HJ. Surveillance in Lynch syndrome. Fam Cancer. 2005;4(3):267-71.
Prieto V. Muir-Torre Syndrome. Medscape Reference. Drugs, Diseases & Procedures. Available from: http://emedicine.medscape.com/article/1093640-overview. Accessed in 2013 (Jun 13).
Graefe T, Wollina U, Schulz H, Burgdorf W. Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology. 2000;200(4):331-3.
Rodríguez-Bigas MA, Vasen HF, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997;225(2):202-7.
Burke W, Petersen G, Lynch P, et al. Recommendations for follow- up care of individuals with an inherited predisposition to cancer.
I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997;277(11):915-9.
